Patent Application
20150191396
The invention relates to ceramic components, In particular implants, for fusing vertebral bodies, and to methods for producing these ceramic components.
Components for fusing vertebral bodies based on metal materials such as e.g. tantalum or titanium are known. A drawback of these metal materials is for instance a high risk of infection. Moreover, metal implants may be medically contraindicated if there is an allergy or hypersensitivity to metals or metal-like materials. Metal abrasion may have negative effects on the human organism. Artifacts from metal implants may greatly impede imaging in medical diagnostics.
Components based on plastics, such as e.g. highly cross-linked PE materials or PEEK, are also known. Disadvantages of the plastics are that, e.g., the mechanical properties may be unsatisfactory, which may lead, e.g., to tips or other parts of the component breaking off, for instance during insertion. Moreover, components or implants based on plastics cannot be imaged, or cannot be adequately imaged, with many current imaging methods, e.g. MRI and X-rays, so that for instance specific markers must be used.
Ceramic components based on silicon nitride are also known. However, this class of materials was developed with excellent high temperature properties in mind—for instance for mechanical machining of metal components for the automobile industry—and in terms of the properties required for this application, such as strength, hardness, and long-term stability, is more in the mid-range compared to other high-performance ceramic materials based on oxide systems. In addition, this material is a relatively complicated material containing needle-shaped silicon nitride, which is embedded in a glass matrix. Therefore, sintering the material is complex. Moreover, mechanical machining processes such as grinding and polishing are very demanding and difficult because the material is very hard and nonhomogeneous. In addition, components produced from silicon nitride have a rather dark coloring—gray to black—which in the medical field is less accepted for reasons of appearance alone. All of these disadvantages lead to increased costs in producing the components, which represents a further drawback.
The object of the invention is therefore to provide a method for producing a component for fusing vertebral bodies, and to provide a component for fusing vertebral bodies that avoids the aforesaid disadvantages and in particular has adequate strength, hardness, and long-term stability. The object of the invention is further to provide a method that imposes as few special requirements as possible on the machining process.
The object is achieved using a component for fusing vertebral bodies in accordance with claim 1 and a method for producing this component in accordance with claim 8.
The component according to the invention for fusing vertebral bodies consequently is made of an oxide ceramic. The produced products have the advantages of oxide ceramics. Oxide ceramics are distinguished in particular by high durability in, and good tolerance with, body media. Oxide ceramics have good biocompatibility and do not cause any allergic reactions.
Consequently, the invention includes a ceramic component for fusing vertebral bodies, especially in the area of the human vertebral column. In accordance with one preferred embodiment of the invention, the component is based on oxide ceramic material systems, including:
A few of the materials in question shall be briefly described in the following.
ZTA may be produced, for instance, from materials having the following composition: 72 to 82 wt. % Al2O3, 28 to 18 wt. % ZrO2, 0 to 1 wt. % Cr2O3, 0 to 6 wt. % Y2O3 relative to the ZrO2 content, 0 to 2 wt. % SrO, 0 to 0.5 wt. %, TiO2, and 0 to 0.5 wt. % MgO.
One preferred embodiment of the invention includes a material having the following composition: 72.65 to 74.54 wt. % Al2O3, 24.0 to 25.5 wt. % ZrO2, 0.5 to 0.65 wt. % Y2O3 relative to the Al2O3 content, 0.26 to 0.35 Cr2O3, and 0.70 to 0.85 wt. % SrO.
In accordance with another preferred embodiment of the invention, the component has the following composition: 70 to 90 wt. % Al2O3:Cr (aluminum oxide with chromium doping), 12 to 22 wt. % ZrO2:Y (yttrium-stabilized zirconium oxide) and 1 to 5 wt. % SrAl12-xCrxO19 (strontium aluminate with variable chromium doping, where x is preferably between 0.0007 and 0.045).
Naturally, all refinements and all variants of these material classes are also in principle suitable for the component according to the invention, such as e.g. composite materials based on yttrium-stabilized zirconium oxide with strontium hexaaluminate as the secondary, dispersoid, toughening phase in the structure (SHYTZ).
The geometry of the component is matched to the anatomy of the human vertebral body. The component is seated between two vertebral bodies and replaces all or part of the intervertebral disk. In a first phase of its residence in the human body, the component holds the vertebral bodies at a distance and in an anatomically correct position solely by virtue of its mechanical properties. In a second phase, the component promotes fusing, and thus the growing together of the two vertebral bodies between which it is inserted.
For the first phase, the so-called primary stability immediately following the surgery and prior to osseointegration is important. This may be attained, for instance, in that morphological moldings that ensure slip-proof connection of the adjacent vertebrae are provided on the top and bottom sides of the component, which are in contact with the adjacent vertebrae. Such morphological moldings may be pointed, pyramidal, or knob-shaped structures, for instance. By means of these structures, the components can hook onto the vertebral bodies, or the component is fixed in the position in which it was inserted.
Mechanical stability is assured by the excellent mechanical material properties of the aforesaid material classes. Ideally, the component is embodied in an annular or banana shape, wherein the geometry and size are adapted to the different areas of the vertebral column (e.g. cervical or lumbar area). In addition, the shape of the component plays an important role in the insertion or implantation in the human body. Different component shapes that are known per se to the person skilled in the art are required for different implantation methods.
In accordance with one advantageous refinement of the invention, the component has an outer, solid or completely ceramic part that is extremely well suited for the mechanical, biological, and chemical requirements during implantation and also while it remains in the human body.
The component preferably also has an inner part that is configured in such a way that conditions are optimal for human bone cells (e.g. osteoblasts) or cells that are necessary for the formation of human bone tissue (ossification). The goal here is complete bony integration into the human vertebral column, so-called osseointegration.
In accordance with a first variant, this inner part may be hollow; that is, it may be merely an empty area free of ceramic, that may be used for introducing the body's own, or autologous, bone material, preferably together with known substances that promote ossification.
In a second variant, this inner part may also be porous; that is, it may be embodied as a porous, preferably ceramic structure. This porous structure may particularly preferably be implemented on the basis of the same ceramic material as the outer part. It has been found that the following properties of an implant have a positive effect on ossification:
The structure of the inner part may be produced by means of different methods, in particular directly during the process of producing the ceramic component, or separately by subsequently introducing the inner part into the outer part.
The direct production processes include, e.g., a two-component injection molding process in which preferably the outer part is first cast in a mold and then the inner part is cast, especially by suitably modifying the mold. The two parts are subsequently co-sintered and undergo final machining.
The inner part may also be produced as a foam-like structure, for instance by freeze direct foaming. In accordance with another alternative, organic materials may be added to a ceramic slurry and subsequently burned out so that pores remain.
During separate production and subsequent introduction of the inner part into the outer part, the two structures, the outer part and inner part, are molded and sintered independently of one another and are not combined until a second step, preferably by mechanical means. Direct molding processes may for instance be used during separate production of the inner part. In this case, polyurethane foams are suitable which, after appropriate pretreatment to produce a suitable structure, are impregnated with ceramic slurry and then burned out. For the purpose of direct molding, biomimetic methods may also be used which per se have a trabecular bone structure or a similar structure. For instance, organic materials like bamboo are suitable for this purpose.
It is also possible to produce the structures of the inner part in a defined fashion using generative methods, for instance by means of printing methods or dispense plotting. Printing methods have the advantage that the geometry of the individual pores of the porous structure may be defined and produced periodically. Thus, it is possible from a technical standpoint to design, develop, and produce an optimal scaffold for the biological-chemical processes during ossification.
For additionally increasing osseoinductivity or bioactivity, the structures of the inner and/or outer part may be coated with common functional coatings such as e.g. hydroxyapatite or tricalcium phosphate or other calcium phosphates that promote osseointegration, e.g. Fillings based on bioglass ceramic materials that have a high proportion of SiO2, CaO, P2O5, and/or K2O are also suitable for this purpose. The component or just only the Inner or outer part may also be coated with this material.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10 2012 212 138.2 | Jul 2012 | DE | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2013/064440 | 7/9/2013 | WO | 00 |
